Cerevel Therapeutics Holdings, Inc.

CERENASDAQ Capital Market·USD·Closed

CERENASDAQ·USD·Closed

$44.96

+0.74%

$44.96

+$0.33 (0.74%)

52W Range

100thpctl

Volume

7.12×avg

Mkt Cap

8.19BUSD

P/E

-16.8TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

100thpctl

Volume

7.12×avg

Market Cap

8.19BUSD

P/E Ratio

-16.8TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-38.7%

Financially safe

Stretched

Debt / equity0.71×

Interest coverage-42.3×

Current ratio10.92×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required